{"doi":"10.1183/13993003.01983-2019","title":"Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study","abstract":null,"journal":"European Respiratory Journal","year":2020,"id":45774,"datarank":2.9652500273299225,"base_score":4.499809670330265,"endowment":4.499809670330265,"self_citation_contribution":0.6749714505495399,"citation_network_contribution":2.290278576780383,"self_endowment_contribution":0.6749714505495399,"citer_contribution":2.290278576780383,"corpus_percentile":null,"corpus_rank":null,"citation_count":89,"citer_count":69,"citers_with_citation_signal":53,"citers_with_endowment":53,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":213292,"name":"Frederik Hermans","orcid":null,"position":1,"is_corresponding":false},{"id":213293,"name":"Els De Dycker","orcid":null,"position":2,"is_corresponding":false},{"id":213294,"name":"Jonas Yserbyt","orcid":null,"position":3,"is_corresponding":false},{"id":213295,"name":"Johny A. Verschakelen","orcid":null,"position":4,"is_corresponding":false},{"id":213296,"name":"Eric K. Verbeken","orcid":null,"position":5,"is_corresponding":false},{"id":213297,"name":"Geert M. Verleden","orcid":null,"position":6,"is_corresponding":false},{"id":551,"name":"Stijn E. Verleden","orcid":"0000-0002-9656-5844","position":7,"is_corresponding":false},{"id":49096,"name":"Wim A. Wuyts","orcid":"0000-0001-9648-3497","position":8,"is_corresponding":false},{"id":49087,"name":"Laurens J. De Sadeleer","orcid":"0000-0003-1237-7369","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.499809670330265,"endowment":4.499809670330265,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"31949120","pmcid":null,"openalex_id":"https://openalex.org/W2999937905","authors":[],"funders":[{"funder_name":"Fonds Wetenschappelijk Onderzoek","grant_id":"1.8.325.12N","title":null}],"total_grants":1,"fwci":7.2718,"citation_percentile":0.97860902,"influential_citations":1,"citation_trend":[{"year":2019,"count":1},{"year":2020,"count":9},{"year":2021,"count":32},{"year":2022,"count":10},{"year":2023,"count":8},{"year":2024,"count":14},{"year":2025,"count":7},{"year":2026,"count":8}],"oa_status":"bronze","license":"https://www.ersjournals.com/user-licence","oa_locations":[{"url":"https://erj.ersjournals.com/content/erj/55/4/1901983.full.pdf","host_type":"journal"},{"url":"https://erj.ersjournals.com/content/erj/55/4/1901983.full.pdf","host_type":"BRONZE"},{"url":"https://erj.ersjournals.com/content/erj/55/4/1901983.full.pdf","host_type":"publisher"},{"url":"https://syndication.highwire.org/content/doi/10.1183/13993003.01983-2019","host_type":"publisher"},{"url":"https://doi.org/10.1183/13993003.01983-2019","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/31949120","host_type":"repository"},{"url":"https://lirias.kuleuven.be/bitstream/123456789/648982/2/13993003.01983-2019.full.pdf","host_type":"repository"}],"fields_of_study":["Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","IL-33, ST2, and ILC Pathways","Systemic Sclerosis and Related Diseases","Medicine","Adrenal Cortex Hormones","Alveolitis, Extrinsic Allergic","Bronchoalveolar Lavage Fluid","Humans","Lymphocytosis","Pulmonary Fibrosis","Retrospective Studies"],"mesh_terms":["Adrenal Cortex Hormones","Alveolitis, Extrinsic Allergic","Bronchoalveolar Lavage Fluid","Humans","Lymphocytosis","Pulmonary Fibrosis","Retrospective Studies"],"keywords":["Hypersensitivity pneumonitis","Medicine","Honeycombing","Lymphocytosis","Bronchoalveolar lavage","Pulmonary fibrosis","Internal medicine","Gastroenterology","Idiopathic pulmonary fibrosis","Corticosteroid","Retrospective cohort study","Lung"],"sdg_mappings":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.14227705.v1","title":"Additional file 10 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227705","title":"Additional file 10 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227708.v1","title":"Additional file 11 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227708","title":"Additional file 11 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227711.v1","title":"Additional file 12 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227711","title":"Additional file 12 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227714.v1","title":"Additional file 13 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227714","title":"Additional file 13 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227717.v1","title":"Additional file 14 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227717","title":"Additional file 14 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227720.v1","title":"Additional file 1 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227720","title":"Additional file 1 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227723.v1","title":"Additional file 2 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227723","title":"Additional file 2 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227726.v1","title":"Additional file 3 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227726","title":"Additional file 3 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227729.v1","title":"Additional file 4 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227729","title":"Additional file 4 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227732","title":"Additional file 5 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227732.v1","title":"Additional file 5 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227735.v1","title":"Additional file 6 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227735","title":"Additional file 6 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227738.v1","title":"Additional file 7 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227738","title":"Additional file 7 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.14227741.v1","title":"Additional file 8 of Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-04T02:02:57.865698Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}